Influenza Clinical Trial
Official title:
Combining Entertainment & Education Into an Age Appropriate Intervention Geared Toward Increasing Influenza Vaccination of Pediatric Patients in Underserved Communities
The investigators have developed an influenza-vaccination-education-study-program that will involve the use of an animated influenza vaccine-based computer program (videogame) that is designed from the investigator's own initiative. The investigators propose implementing an influenza vaccination educational program in the pediatric satellite office that serves a population that has historical low rates of influenza vaccination.
Each year, during the fall and winter, coinciding with the influenza season, the number of
health care visits and the number of days missed from school increases due to febrile
respiratory illnesses. The highest rates of influenza infections are present amongst
school-age children. The vaccination against seasonal influenza remains the most important
measure to prevent infection and to combat the overall spread of the virus. School-age
children, in particular, adolescents, may not be aware of the need for influenza vaccination.
Interactive computerized educational programs have been developed and used in different
pediatric settings in an attempt to increase children's understanding of their medical
condition, and improve adherence to the treatment.
The investigators identified one of our satellite pediatric clinics, as being the perfect
venue for an intervention that will attempt to increase influenza vaccination. The clinic is
located in an underserved area. More than 9,000 children are seen annually in this clinic
with about 20% of the patients age 8 and above. A pediatric pulmonary office, part of the
pediatric clinic, serves a high number of patients, most of whom have poorly controlled
asthma.
Currently, no focused, developmentally appropriate education programs regarding vaccination
are used in our outpatient clinics.
The investigators propose implementing an influenza vaccination educational program in this
pediatric satellite office that serves a population that has historical low rates of
influenza vaccination.
The investigators have developed an influenza-vaccination-education-study-program that will
involve the use of an animated influenza vaccine-based computer program (videogame) that is
designed from the investigator's own initiative. This videogame should provide a basis or
foundation to discuss the need for influenza vaccination and the adverse effects of influenza
disease. It will be designed to intrigue the child by providing animated tours and creative
experiences that are designed to encourage behavioral changes towards the need for
vaccination.
The investigators hypothesis that by using this hybrid entertainment-educational tool, we
will increase children's knowledge about influenza disease and the need for influenza
vaccination. By using this age appropriate intervention, we aim to decrease children and
adolescent's anxiety related to the vaccination and to increase vaccination rates. The
investigators hypothesis that our intervention will have a high impact since it is geared to
an ethnic community with historically low rates of influenza vaccination.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05523089 -
The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults
|
Phase 2 | |
| Completed |
NCT05009251 -
Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake
|
N/A | |
| Completed |
NCT03282240 -
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US
|
Phase 3 | |
| Completed |
NCT00968526 -
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
|
Phase 3 | |
| Completed |
NCT00971425 -
Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)
|
Phase 3 | |
| Completed |
NCT00968539 -
Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults
|
Phase 3 | |
| Completed |
NCT05525494 -
Patient Portal Flu Vaccine Reminders (5)
|
N/A | |
| Completed |
NCT04074928 -
Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects
|
Phase 3 | |
| Completed |
NCT04695717 -
This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam
|
Phase 3 | |
| Completed |
NCT05012163 -
Lottery Incentive Nudges to Increase Influenza Vaccinations
|
N/A | |
| Completed |
NCT04109222 -
Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively
|
Phase 4 | |
| Completed |
NCT03888989 -
Response to Influenza Vaccine During Pregnancy
|
Phase 1 | |
| Completed |
NCT02587221 -
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age
|
Phase 3 | |
| Completed |
NCT03453801 -
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection
|
Phase 1 | |
| Completed |
NCT01440387 -
A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older
|
Phase 3 | |
| Terminated |
NCT01195779 -
Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children
|
Phase 2 | |
| Completed |
NCT03321968 -
Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults
|
Phase 3 | |
| Completed |
NCT00972517 -
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children
|
Phase 3 | |
| Completed |
NCT04570904 -
Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
|
||
| Recruiting |
NCT03331991 -
Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel
|
N/A |